Testosterone Class Action Lawsuit
Testosterone therapy has become much more prevalent since 2010. This is evidenced by the Food and Drug Administration (FDA) stating that 2013 estimates showed that 1.5 million men were taking a testosterone replacement product, this number is found to be near double of what it was in 2010.Learn More
Have questions? Contact our Testosterone Class Action Lawsuit Attorney – 720-515-7058
With the severity of the injuries that can be caused by these drugs, it’s scary to know the amount of individuals that are using these drugs. In fact, it is estimated that testosterone therapy drugs generate around $2 billion dollars in revenue in the United States each year. Knowing the large amount of revenue generated each year by these drugs, it’s no surprise that companies continue to push them on men – to try and increase their profits.
Yet, these drugs shouldn’t be taken without knowing all the information, and risks. The FDA in 2015 stated testosterone therapies should not be given to individuals unless their low testosterone is associated with a medical condition. For more information see fda.gov There is a concern that testosterone therapy drugs are being prescribed to individuals who should not be taking them, in addition, these individuals aren’t apprised of the potential risks.
As noted the use of these testosterone replacement therapies has been skyrocketing – no doubt to the influx of advertisements attempting to sell these products. These advertisements claim, these “Low T” treatments are for men who have lost a step and/or are experiencing a diminished libido as a result of aging. These drugs claim they can help an individual get back an increased libido and increase energy levels.
Yet unfortunately, these drugs are causing unintended cardiovascular injuries such as:
- Heart Attack
- Pulmonary Embolism
- Deep Vein Thrombosis
- Serious Blood Clot Injury
These injuries, negative consequences from these “Low T” therapies are becoming so severe, that in March of 2015, the (FDA) issued a safety alert regarding the use of testosterone in men whose “Low T” levels are due to the normal aging process, not hypogonadism or other health conditions. The FDA stated – “Healthcare professionals should prescribe testosterone therapy only for men with low testosterone levels caused by certain medical conditions and confirmed by laboratory tests”.
In November 2013, the Journal of American Medical Association (JAMA), stated that they found a 30 percent increased risk of death, heart attack or stroke among men who were taking testosterone replacement drugs, compared to those who were not taking them. A separate study from the National Institutes of Health (NIH) had similar findings, concluding that men over sixty-five who were taking testosterone replacement drugs had double the rate of heart attacks, when compared with men of similar age who were not taking these replacement drugs.